|
1
|
Riedemann NC, Guo RF and Ward PA: Novel
strategies for the treatment of sepsis. Nat Med. 9:517–524. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang H, Bloom O, Zhang M, Vishnubhakat JM,
Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et
al: HMG-1 as a late mediator of endotoxin lethality in mice.
Science. 285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang H, Ward MF and Sama AE: Targeting
HMGB1 in the treatment of sepsis. Expert Opin Ther Targets.
18:257–268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang W, Tang Y and Li L: HMGB1, a potent
proinflammatory cytokine in sepsis. Cytokine. 51:119–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gerstberger S, Hafner M and Tuschl T: A
census of human RNA-binding proteins. Nat Rev Genet. 15:829–845.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu H, Berkova Z, Mathur R, Sehgal L,
Khashab T, Tao RH, Ao X, Feng L, Sabichi AL, Blechacz B, et al: HuR
suppresses fas expression and correlates with patient outcome in
liver cancer. Mol Cancer Res. 13:809–818. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Poria DK, Guha A, Nandi I and Ray PS:
RNA-binding protein HuR sequesters microRNA-21 to prevent
translation repression of proinflammatory tumor suppressor gene
programmed cell death 4. Oncogene. 35:1703–1715. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang M, Cao L, Xie M, Yu Y, Kang R, Yang
L, Zhao M and Tang D: Chloroquine inhibits HMGB1 inflammatory
signaling and protects mice from lethal sepsis. Biochem Pharmacol.
86:410–418. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nabors LB, Gillespie GY, Harkins L and
King PH: HuR, a RNA stability factor, is expressed in malignant
brain tumors and binds to adenine- and uridine-rich elements within
the 3′ untranslated regions of cytokine and angiogenic factor
mRNAs. Cancer Res. 61:2154–2161. 2001.PubMed/NCBI
|
|
11
|
Bae JS and Rezaie AR: Activated protein C
inhibits high mobility group box 1 signaling in endothelial cells.
Blood. 118:3952–3959. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bae JS and Rezaie AR: Thrombin inhibits
HMGB1-mediated proinflammatory signaling responses when endothelial
protein C receptor is occupied by its natural ligand. BMB Rep.
46:544–559. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buras JA, Holzmann B and Sitkovsky M:
Animal models of sepsis: Setting the stage. Nat Rev Drug Discov.
4:854–865. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Berman RS, Frew JD and Martin W:
Endotoxin-induced arterial endothelial barrier dysfunction assessed
by an in vitro model. Br J Pharmacol. 110:1282–1284. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wolfson RK, Chiang ET and Garcia JG: HMGB1
induces human lung endothelial cell cytoskeletal rearrangement and
barrier disruption. Microvasc Res. 81:189–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hansson GK and Libby P: The immune
response in atherosclerosis: A double-edged sword. Nat Rev Immunol.
6:508–519. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dagdeviren S, Jung DY and Friedline RH:
IL-10 prevents aging-associated inflammation and insulin resistance
in skeletal muscle. FASEB J. 31:701–710. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cohen J: The immunopathogenesis of sepsis.
Nature. 420:885–891. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Teiten MH, Eifes S, Dicato M and Diederich
M: Curcumin-the paradigm of a multi-target natural compound with
applications in cancer prevention and treatment. Toxins. 2:128–162.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perl TM, Dvorak L, Hwang T and Wenzel RP:
Long-term survival and function after suspected Gram-negative
sepsis. JAMA. 274:338–345. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li W, Zhu S, Zhang Y, Li J, Sama AE, Wang
P and Wang H: Use of animal model of sepsis to evaluate novel
herbal therapies. J Vis Exp pii. 39262012.
|
|
22
|
Yoo H, Ku SK, Lee T and Bae JS: Orientin
inhibits HMGB1-induced inflammatory responses in HUVECs and in
murine polymicrobial sepsis. Inflammation. 37:1705–1717. 2014.
View Article : Google Scholar : PubMed/NCBI
|
